These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5006772)

  • 1. Glucose suppression of serum growth hormone in the diagnosis of acromegaly.
    Earll JM; Sparks LL; Forsham PH
    JAMA; 1967 Aug; 201(8):628-30. PubMed ID: 5006772
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of oral glucose tolerance in the diagnosis of acromegaly].
    von Werder K; Bottermann P; Hartmann P; Schwarz K
    Med Klin; 1972 Oct; 67(43):1398-401. PubMed ID: 4641922
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum human growth hormone (HGH) response to IV glucose: diagnosis of acromegaly in females and males.
    Boden G; Soeldner JS; Steinke J; Thorn GW
    Metabolism; 1968 Jan; 17(1):1-9. PubMed ID: 5638674
    [No Abstract]   [Full Text] [Related]  

  • 4. Cryohypophysectomy for acromegaly. Factors associated with altered endocrine function and carbohydrate metabolism.
    Levin SR; Hofeldt FD; Schneider V; Becker N; Karam JH; Seymour RJ; Adams JE; Forsham PH
    Am J Med; 1974 Oct; 57(4):526-35. PubMed ID: 4432860
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnostic value of hGH glucose suppression test in acromegaly (author's transl)].
    Deng JY
    Zhonghua Nei Ke Za Zhi; 1981 Aug; 20(8):467-70. PubMed ID: 7338080
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of the peroral TRH test in the diagnosis of acromegaly].
    Felt V; Nedvídková J
    Vnitr Lek; 1977 Sep; 23(9):865-7. PubMed ID: 411251
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term treatment of acromegaly with bromocryptine: postprandial HGH levels and response to TRH and glucose administration.
    Benker G; Zäh W; Hackenberg K; Hamburger B; Günnewig H; Reinwein D
    Horm Metab Res; 1976 Jul; 8(4):291-5. PubMed ID: 182633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly.
    Grinspoon S; Clemmons D; Swearingen B; Klibanski A
    J Clin Endocrinol Metab; 1995 Mar; 80(3):927-32. PubMed ID: 7533774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chlorpromazine on serum growth-hormone concentration in man.
    Sherman L; Kim S; Benjamin F; Kolodny HD
    N Engl J Med; 1971 Jan; 284(2):72-4. PubMed ID: 5538637
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels.
    Yen SS; Siler TM; DeVane GW
    N Engl J Med; 1974 Apr; 290(17):935-8. PubMed ID: 4593614
    [No Abstract]   [Full Text] [Related]  

  • 11. GH response to oral and intravenous glucose load in acromegalic patients.
    Mancini A; Zuppi P; Fiumara C; Valle D; Conte G; Fabrizi ML; Sammartano L; Anile C; Maira G; De Marinis L
    Horm Metab Res; 1995 Jul; 27(7):322-5. PubMed ID: 7590615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of growth-hormone secretion.
    Burger HG; Catt KJ
    Lancet; 1969 Jun; 1(7607):1213. PubMed ID: 4181864
    [No Abstract]   [Full Text] [Related]  

  • 13. Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly.
    Wass JA
    J Endocrinol; 1997 Oct; 155 Suppl 1():S17-9; discussion S21. PubMed ID: 9389991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acromegaly with 'normal' serum growth hormone levels. Clinical features, diagnosis and results of transsphenoidal microsurgery.
    Brockmeier SJ; Buchfelder M; Adams EF; Schott W; Fahlbusch R
    Horm Metab Res; 1992 Aug; 24(8):392-400. PubMed ID: 1526628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of acromegaly by radioimmunoassay of somatomedin-C.
    Clemmons DR; Van Wyk JJ; Ridgway EC; Kliman B; Kjellberg RN; Underwood LE
    N Engl J Med; 1979 Nov; 301(21):1138-42. PubMed ID: 492275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma growth hormone response to thyrotropin-releasing hormone in patients with active acromegaly.
    Faglia G; Beck-Peccoz P; Ferrari C; Travaglini P; Ambrosi B; Spada A
    J Clin Endocrinol Metab; 1973 Jun; 36(6):1259-62. PubMed ID: 4196265
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acromegaly. 3. Significance of the dynamic study of somatotropin].
    Marek J; Srámková J; Bleha O; Engelberth O
    Cas Lek Cesk; 1973; 112(28):849-53. PubMed ID: 4720439
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of growth hormone-releasing factor on growth hormone secretion in acromegaly.
    Gelato MC; Merriam GR; Vance ML; Goldman JA; Webb C; Evans WS; Rock J; Oldfield EH; Molitch ME; Rivier J
    J Clin Endocrinol Metab; 1985 Feb; 60(2):251-7. PubMed ID: 3917454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of serum GH, IGF-1 and IGFBP3 in patients of acromegaly with uncontrolled diabetes: a pilot study.
    Dutta P; Singhal S; Sachdeva NK; Shah VN; Pathak A; Mukherjee KK; Bhansali A
    J Assoc Physicians India; 2014 Aug; 62(8):686-90. PubMed ID: 25856936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone responses to oral glucose loading measured by highly sensitive enzyme immunoassay in normal subjects and patients with glucose intolerance and acromegaly.
    Hattori N; Shimatsu A; Kato Y; Koshiyama H; Ishikawa Y; Assadian H; Tanoh T; Nagao M; Imura H
    J Clin Endocrinol Metab; 1990 Mar; 70(3):771-6. PubMed ID: 2106529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.